InsiderTrades.com logo

NRXP Insider Trading

Insider Ownership Percentage: 19.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

NRx Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at NRx Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NRx Pharmaceuticals Share Price & Price History

Current Price: $1.88
Price Change: ▲ Price Increase of +0.12 (6.82%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for NRXP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NRx Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2024Jonathan C JavittChairmanBuy40,000$1.17$46,800.0084,634View SEC Filing Icon  
8/30/2023Aaron GorovitzDirectorBuy3,500$3.20$11,200.0010,500View SEC Filing Icon  
8/22/2023Jonathan C JavittInsiderBuy20,000$3.20$64,000.0034,633View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NRx Pharmaceuticals (NASDAQ:NRXP)

4.27% of NRx Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NRXP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NRx Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026Anson Funds Management LP3,043,957$8.25M0.8%+50.3%10.284%Search for SEC Filing on Google Icon
2/13/2026State Street Corp86,984$0.24M0.0%+14.0%0.294%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC366,631$0.99M0.0%N/A1.238%Search for SEC Filing on Google Icon
2/10/2026AdvisorShares Investments LLC328,004$0.89M0.1%-4.1%1.108%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC218,866$0.59M0.0%+17.8%0.739%Search for SEC Filing on Google Icon
2/9/2026Bleakley Financial Group LLC117,204$0.32M0.0%N/A0.396%Search for SEC Filing on Google Icon
2/6/2026Global Retirement Partners LLC39,300$0.11M0.0%N/A0.133%Search for SEC Filing on Google Icon
1/14/2026Sjbenen Advisory LLC15,000$41K0.0%N/A0.051%Search for SEC Filing on Google Icon
1/14/2026One Wealth Management Investment & Advisory Services LLC37,873$0.10M0.1%+35.3%0.128%Search for SEC Filing on Google Icon
11/17/2025Anson Funds Management LP2,025,104$6.68M0.6%+26.2%10.223%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP52,332$0.17M0.0%+66.4%0.264%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.534,956$1.77M0.0%+18.3%2.700%Search for SEC Filing on Google Icon
11/5/2025AdvisorShares Investments LLC342,136$1.13M0.2%+29.7%1.727%Search for SEC Filing on Google Icon
10/29/2025One Wealth Management Investment & Advisory Services LLC27,991$92K0.1%+86.1%0.141%Search for SEC Filing on Google Icon
10/23/2025Ethos Financial Group LLC11,900$39K0.0%N/A0.060%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP33,384$0.11M0.0%-62.5%0.193%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC172,255$0.56M0.0%+27.9%0.996%Search for SEC Filing on Google Icon
8/4/2025AdvisorShares Investments LLC263,797$0.86M0.2%-8.0%1.526%Search for SEC Filing on Google Icon
5/28/2025Anson Funds Management LP1,179,061$2.42M0.4%+535.1%6.820%Search for SEC Filing on Google Icon
5/14/2025Anson Funds Management LP1,179,061$2.42M0.3%+535.1%6.845%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC25,299$56K0.0%N/A0.161%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC27,624$61K0.0%N/A0.176%Search for SEC Filing on Google Icon
2/17/2025Anson Funds Management LP185,660$0.41M0.0%+30.3%1.183%Search for SEC Filing on Google Icon
2/14/2025AdvisorShares Investments LLC310,314$0.68M0.1%+138.5%1.977%Search for SEC Filing on Google Icon
2/14/2025Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096%Search for SEC Filing on Google Icon
11/15/2024Anson Funds Management LP142,525$0.24M0.0%N/A1.326%Search for SEC Filing on Google Icon
11/13/2024Townsquare Capital LLC15,041$25K0.0%N/A0.140%Search for SEC Filing on Google Icon
8/8/2024AdvisorShares Investments LLC108,085$0.28M0.0%-82.4%1.010%Search for SEC Filing on Google Icon
8/6/2024One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141%Search for SEC Filing on Google Icon
2/14/2024AdvisorShares Investments LLC642,632$0.30M0.1%N/A0.755%Search for SEC Filing on Google Icon
1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165%Search for SEC Filing on Google Icon
11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065%Search for SEC Filing on Google Icon
2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086%Search for SEC Filing on Google Icon
1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044%Search for SEC Filing on Google Icon
1/27/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%Search for SEC Filing on Google Icon
1/18/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%Search for SEC Filing on Google Icon
11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094%Search for SEC Filing on Google Icon
5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023%Search for SEC Filing on Google Icon
4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027%Search for SEC Filing on Google Icon
2/9/2022Wolverine Asset Management LLC37,105$0.18M0.0%-12.8%0.063%Search for SEC Filing on Google Icon
2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NRx Pharmaceuticals logo
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.
Read More on NRx Pharmaceuticals

Today's Range

Now: $1.88
Low: $1.80
High: $1.91

50 Day Range

MA: $2.17
Low: $1.68
High: $2.71

52 Week Range

Now: $1.88
Low: $1.58
High: $3.84

Volume

949,952 shs

Average Volume

531,760 shs

Market Capitalization

$59.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Who are the company insiders with the largest holdings of NRx Pharmaceuticals?

NRx Pharmaceuticals' top insider investors include:
  1. Jonathan C Javitt (Chairman)
Learn More about top insider investors at NRx Pharmaceuticals.

Who are the major institutional investors of NRx Pharmaceuticals?

NRx Pharmaceuticals' top institutional investors include:
  1. Anson Funds Management LP — 10.28%
  2. Commonwealth Equity Services LLC — 1.24%
  3. AdvisorShares Investments LLC — 1.11%
  4. Geode Capital Management LLC — 0.74%
  5. Bleakley Financial Group LLC — 0.40%
  6. State Street Corp — 0.29%
Learn More about top institutional investors of NRx Pharmaceuticals stock.

Which institutional investors are selling NRx Pharmaceuticals stock?

In the previous quarter, NRXP stock was sold by these institutional investors:
  1. AdvisorShares Investments LLC

Which institutional investors are buying NRx Pharmaceuticals stock?

In the previous quarter, NRXP stock was bought by institutional investors including:
  1. Anson Funds Management LP
  2. Commonwealth Equity Services LLC
  3. Bleakley Financial Group LLC
  4. Global Retirement Partners LLC
  5. Geode Capital Management LLC
  6. Sjbenen Advisory LLC
  7. State Street Corp
  8. One Wealth Management Investment & Advisory Services LLC